




|
Autism - antibiotic therapy - 24340 Antibiotic therapy and/or chronic history of antibiotic use triggers onset in previously normal children. [Clinical Chemistry, 1995;41(8):1094-1104. 24340 (1996)] Summary Interview PubMed |
|
Autism - detoxification - sauna therapy - 37211 Detoxification - sauna therapy up to 160 degrees for 30 minutes four times a day under very strict medical supervision for chemicals and/or chelation therapy for heavy metals using DMPS, DMSA, and EDTA and the natural chelators glutathione, N-Acetyl-Cysteine and lipoic acid. [Toxicol Indust Health, 2000;16(6):239-247. 37211; Toxicol Indust Health, Nov-Dec 1998;14(6):799-811 (2001)] Summary Interview PubMed |
|
Autism - docosahexaenoic acid - 38250 Docosahexaenoic acid (DHA) significantly reduced in the plasma of 15 autistic children. [Prostaglandins, Leukot and Essent Fatty acids, 2001;65:1-7. 38250 (2001)] Summary Interview PubMed |
|
Autism - hyperbaric oxygen therapy - 46281 Hyperbaric Oxygen Therapy (HBOT) - 1.5 atm and 100% oxygen or 1.3 atm and 24% oxygen x 40 treatments [Med Hypotheses, 2006;67(2):216-28. Epub 2006 Mar 22. 46281 (4/2007) Summary Interview PubMed |
|
Autism - immunizations - 37211 Immunizations play a role but are the main cause in children. [Toxicol Indust Health, 2000;16(6): 239-247 37211; Toxicol Indust Health, Nov-Dec 1998;14(6):799-811 (2002)] Summary Interview PubMed |
|
Autism - multidimensional approach - 37211 Multidimensional approach - nutritional therapy, liver up-regulation therapy, chelation, sauna-heat therapy, antioxidant therapy, a therapy to stop auto-immune encephalopathy and multiple other forms of treatment. [Toxicol Indust Health, 2000;16(6):239-247. 37211; Toxicol Indust Health, Nov-Dec 1998;14(6):799-811. (2002)] Summary Interview PubMed |
|
Autism - nutritional deficiencies - 37211 Nutritional deficiencies (common) - zinc, magnesium, glutathione, sulfate, cysteine, B6, DMG and amino acids. [Toxicol Indust Health, 2000;16(6):239-247. 37211; Toxicol Indust Health, Nov-Dec 1998;14 (6):799-811 (2002)] Summary Interview PubMed |
| Nystatin benefit in case study. [Clinical Chemistry, 1995;41(8):1094-1104. 24340 (1996)] Summary Interview PubMed |
|
Autism - omega-3 fatty acids - 38250 Omega-3 fatty acids (total) significantly reduced in the plasma of 15 autistic children. [Prostaglandins, Leukot and Essent Fatty acids, 2001;65:1-7. 38250 (2001)] Summary Interview PubMed |
|
Autism - omega-3 fatty acids - 48140 Omega-3 fatty acids at a total daily dose of 1.16 gms from DHA (460mg) + EPA (700mg) divided equally into two orange-flavored pudding packets free of artificial colors and gluten given twice daily with meals. [J Autism Dev Disord, 2010 Aug 4; [Epub ahead of print]. 48140 (10/2010)] Summary Interview PubMed |
|
Autism - omega-6:omega-3 fatty acids - 38250 Omega-6:omega-3 fatty acid ratio significantly increased in the plasma of 15 autistic children. [Prostaglandins, Leukot and Essent Fatty acids, 2001;65:1-7. 38250 (2001)] Summary Interview PubMed |
|
Autism - vitamin c - 24982/ 24872 Vitamin C counteracts the motor disabilities of autism (abnormal movement patterns) probably because vitamin C is a competitive antagonist at dopamine receptors. [J Royal Soc Med, May, 1996;89(5):241. 24982/ 24872 (1997)] Summary Interview PubMed |
|
Autism - yeast/fungal metabolites - 24340 Yeast/fungal metabolites (i.e. arabinose) elevated in urine organic acid assessment. [Clinical Chemistry, 1995;41(8):1094-1104. 24340 (1996)] Summary Interview PubMed |
|
Autism - yeast/fungal metabolites - 37211 Toxic heavy metals and/or chemical exposure in conjunction with a genetic predisposition to abnormal liver and heavy metal detoxification. [Toxicol Indust Health, 2000;16(6):239-247 37211; Toxicol Indust Health, Nov-Dec 1998;14(6):799-811 (2001)] Summary Interview PubMed |
| Powered by Sigsiu.NET | ![]() |